the-infoshop.com - The vertical markets research portal
View CartView Cart
Global Information, Inc.
US: +1-860-674-8796
EU: +32-2-535-7543
SG: +65-6223-2436
  Home | Catalog | E-mail Alert | Custom Research | About The Infoshop | Contact Us | Site Map |

* View All Categories

[Report]

The Pharmaceutical Market: Latvia

Published: 2008/01

Contact 24 hrs/day
Table of Contents

Abstract

Around 70% of the Latvian pharmaceutical market is supplied by imports. The European Regional Development Fund and the Latvian government are currently funding the National Programme in the Area of Healthcare 2004-2006, worth 11.3 million lats (US$6.1 million). This report is ideal for executives wanting to understand the key drivers in the pharmaceutical market and have access to a wealth of statistical data, including five-year market projections. Included with the report are 3 free quarterly updated outlook reports, enabling you to keep up to date with market developments for a year.

Latvia is one of the smallest countries in Europe. It joined the EU in May 2004 and NATO two months earlier. The 2006 population is estimated to be 2.3 million, with the most populous city being Riga, the capital. As with other European countries, Latvia has an ageing population, with those aged 65 and over representing 16.5% of the population in 2006, compared to 14.5% in 1999.

Funding for healthcare in Latvia is managed by the State Compulsory Health Insurance Agency, although funds are gathered largely through general taxation. Treatments guaranteed to all Latvians and foreign residents include emergency care, treatment for acute and chronic diseases, maternity care, prevention and treatment of infectious diseases (including tuberculosis and HIV/AIDS), immunisation coverage, oncology, haematology and provision of certain pharmaceuticals to eligible groups.

Around 70% of the pharmaceutical market is supplied by imports. Switzerland, Lithuania and Germany were the leading suppliers in 2004, accounting for almost 50% of imports. Imports have increased in value terms every year since 2001.

The European Regional Development Fund and the Latvian government are currently funding the National Programme in the Area of Healthcare 2004-2006, worth 11.3 million lats (US$6.1 million). The programme consists of a number of projects aimed at improving primary healthcare. One of the objectives is to improve the availability of good quality pharmaceutical care, medicines and objective information regarding medicines.

Table of Contents

[Report]
The Pharmaceutical Market: Latvia
Published: 2008/01
Published by : Espicom Business Intelligence Espicom Business Intelligence

Price:
US $ 1,220.00 Hard Copy
US $ 1,220.00 PDF by E-mail (Single User License)
>
Product Code : ES20116
Please inform me when related publications are released
InfoWatch

Available 24 Hours a Day
US: 1-860-674-8796 EU: 32-2-535-7543 SG: 65-6223-2436
The vertical markets research portal
© 2008, the-infoshop.com by Global Information, Inc. All rights reserved.